Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Basal expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to multiple RNA viruses.

Yamane D, Feng H, Rivera-Serrano EE, Selitsky SR, Hirai-Yuki A, Das A, McKnight KL, Misumi I, Hensley L, Lovell W, González-López O, Suzuki R, Matsuda M, Nakanishi H, Ohto-Nakanishi T, Hishiki T, Wauthier E, Oikawa T, Morita K, Reid LM, Sethupathy P, Kohara M, Whitmire JK, Lemon SM.

Nat Microbiol. 2019 Jul;4(7):1096-1104. doi: 10.1038/s41564-019-0425-6. Epub 2019 Apr 15.

2.

TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions.

Das A, Hirai-Yuki A, González-López O, Rhein B, Moller-Tank S, Brouillette R, Hensley L, Misumi I, Lovell W, Cullen JM, Whitmire JK, Maury W, Lemon SM.

mBio. 2017 Sep 5;8(5). pii: e00969-17. doi: 10.1128/mBio.00969-17.

3.

Ecological Risk Assessment of Nano-enabled Pesticides: A Perspective on Problem Formulation.

Walker GW, Kookana RS, Smith NE, Kah M, Doolette CL, Reeves PT, Lovell W, Anderson DJ, Turney TW, Navarro DA.

J Agric Food Chem. 2018 Jul 5;66(26):6480-6486. doi: 10.1021/acs.jafc.7b02373. Epub 2017 Aug 31.

4.

NS5A inhibitors unmask differences in functional replicase complex half-life between different hepatitis C virus strains.

Benzine T, Brandt R, Lovell WC, Yamane D, Neddermann P, De Francesco R, Lemon SM, Perelson AS, Ke R, McGivern DR.

PLoS Pathog. 2017 Jun 8;13(6):e1006343. doi: 10.1371/journal.ppat.1006343. eCollection 2017 Jun.

5.

MAVS-dependent host species range and pathogenicity of human hepatitis A virus.

Hirai-Yuki A, Hensley L, McGivern DR, González-López O, Das A, Feng H, Sun L, Wilson JE, Hu F, Feng Z, Lovell W, Misumi I, Ting JP, Montgomery S, Cullen J, Whitmire JK, Lemon SM.

Science. 2016 Sep 30;353(6307):1541-1545. Epub 2016 Sep 15.

6.

Considerations of Environmentally Relevant Test Conditions for Improved Evaluation of Ecological Hazards of Engineered Nanomaterials.

Holden PA, Gardea-Torresdey JL, Klaessig F, Turco RF, Mortimer M, Hund-Rinke K, Cohen Hubal EA, Avery D, Barceló D, Behra R, Cohen Y, Deydier-Stephan L, Ferguson PL, Fernandes TF, Herr Harthorn B, Henderson WM, Hoke RA, Hristozov D, Johnston JM, Kane AB, Kapustka L, Keller AA, Lenihan HS, Lovell W, Murphy CJ, Nisbet RM, Petersen EJ, Salinas ER, Scheringer M, Sharma M, Speed DE, Sultan Y, Westerhoff P, White JC, Wiesner MR, Wong EM, Xing B, Steele Horan M, Godwin HA, Nel AE.

Environ Sci Technol. 2016 Jun 21;50(12):6124-45. doi: 10.1021/acs.est.6b00608. Epub 2016 Jun 3.

7.

Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.

McGivern DR, Masaki T, Lovell W, Hamlett C, Saalau-Bethell S, Graham B.

J Virol. 2015 May;89(10):5362-70. doi: 10.1128/JVI.03188-14. Epub 2015 Mar 4.

8.

Mechanisms of drug photobinding to proteins: photobinding of suprofen to human serum albumin.

Moser J, Hye A, Lovell WW, Earl LK, Castell JV, Miranda MA.

Toxicol In Vitro. 2001 Aug-Oct;15(4-5):333-7.

PMID:
11566558
9.

Photobinding of ketoprofen in vitro and ex vivo.

Moser J, Sarabia Z, Minter H, Lovell WW, van Henegouwen GM.

J Photochem Photobiol B. 2000 Oct;58(1):37-45.

PMID:
11195851
10.

Photobinding of carprofen to protein.

Moser J, Boscá F, Lovell WW, Castell JV, Miranda MA, Hye A.

J Photochem Photobiol B. 2000 Oct;58(1):13-9.

PMID:
11195847
11.

The second ECVAM workshop on phototoxicity testing. The report and recommendations of ECVAM workshop 42.

Spielmann H, Müller L, Averbeck D, Balls M, Brendler-Schwaab S, Castell JV, Curren R, de Silva O, Gibbs NK, Liebsch M, Lovell WW, Merk HF, Nash JF, Neumann NJ, Pape WJ, Ulrich P, Vohr HW; European Centre for Validation of Alternative Methods.

Altern Lab Anim. 2000 Nov-Dec;28(6):777-814. No abstract available.

PMID:
11105201
12.
13.

Comparison of an in vitro cellular phototoxicity model against controlled clinical trials of fluoroquinolone skin phototoxicity.

Traynor NJ, Barratt MD, Lovell WW, Ferguson J, Gibbs NK.

Toxicol In Vitro. 2000 Jun;14(3):275-83.

PMID:
10806378
14.

Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. European Cosmetic, Toiletry and Perfumery Association.

Diembeck W, Beck H, Benech-Kieffer F, Courtellemont P, Dupuis J, Lovell W, Paye M, Spengler J, Steiling W.

Food Chem Toxicol. 1999 Feb-Mar;37(2-3):191-205. No abstract available.

PMID:
10227743
15.

A Study on UV Filter Chemicals from Annex VII of European Union Directive 76/768/EEC, in the In Vitro 3T3 NRU Phototoxicity Test.

Spielmann H, Balls M, Dupuis J, Pape WJ, de Silva O, Holzhütter HG, Gerberick F, Liebsch M, Lovell WW, Pfannenbecker U.

Altern Lab Anim. 1998 Sep-Oct;26(5):679-708.

PMID:
26042493
16.

The International EU/COLIPA In Vitro Phototoxicity Validation Study: Results of Phase II (Blind Trial). Part 1: The 3T3 NRU Phototoxicity Test.

Spielmann H, Balls M, Dupuis J, Pape WJ, Pechovitch G, de Silva O, Holzhütter HG, Clothier R, Desolle P, Gerberick F, Liebsch M, Lovell WW, Maurer T, Pfannenbecker U, Potthast JM, Csato M, Sladowski D, Steiling W, Brantom P.

Toxicol In Vitro. 1998 Jun 1;12(3):305-27.

PMID:
20654413
17.

British Photodermatology Group Workshop. Predictive in vitro methods for identifying photosensitizing drugs: a report.

Arlett C, Earl L, Ferguson J, Gibbs N, Hawk J, Henderson L, Johnson B, Lovell W, Menagé HD, Navaratnam S, et al.

Br J Dermatol. 1995 Feb;132(2):271-4. No abstract available.

PMID:
7888366
18.

EEC/COLIPA in vitro photoirritancy program: results of the first stage of validation.

Spielmann H, Liebsch M, Pape WJ, Balls M, Dupuis J, Klecak G, Lovell WW, Maurer T, De Silva O, Steiling W.

Curr Probl Dermatol. 1995;23:256-64. Review. No abstract available.

PMID:
9035920
19.

DNA fingerprinting.

Lovell WS.

Science. 1994 Oct 14;266(5183):201-2; author reply 202-3. No abstract available.

PMID:
7939647
20.

Photomutagenicity assays in bacteria: factors affecting assay design and assessment of photomutagenic potential of para-aminobenzoic acid.

Henderson L, Fedyk J, Bourner C, Windebank S, Fletcher S, Lovell W.

Mutagenesis. 1994 Sep;9(5):459-65.

PMID:
7837980
21.

EEC/COLIPA project on in vitro phototoxicity testing: First results obtained with a Balb/c 3T3 cell phototoxicity assay.

Spielmann H, Balls M, Brand M, Döring B, Holzhütter HG, Kalweit S, Klecak G, Eplattenier HL, Liebsch M, Lovell WW, Maurer T, Moldenhauer F, Moore L, Pape WJ, Pfanenbecker U, Potthast J, De Silva O, Steiling W, Willshaw A.

Toxicol In Vitro. 1994 Aug;8(4):793-6.

PMID:
20693013
22.

A screen for photoirritants in cultured cells.

Dixit MB, West M, Earl LK, Lovell WW.

Toxicol In Vitro. 1994 Aug;8(4):759-61.

PMID:
20693005
23.

A scheme for in vitro screening of substances for photoallergenic potential.

Lovell WW.

Toxicol In Vitro. 1993 Jan;7(1):95-102.

PMID:
20732176
24.

The popliteal artery entrapment syndrome in children.

Cummings RJ, Webb HW, Lovell WW, Kay G.

J Pediatr Orthop. 1992 Jul-Aug;12(4):539-41.

PMID:
1613103
25.
26.

Phototoxicity testing in guinea-pigs.

Lovell WW, Sanders DJ.

Food Chem Toxicol. 1992 Feb;30(2):155-60.

PMID:
1555796
27.

The identification of photoallergic potential in the local lymph node assay.

Scholes EW, Basketter DA, Lovell WW, Sarll AE, Pendlington RU.

Photodermatol Photoimmunol Photomed. 1991 Dec;8(6):249-54.

PMID:
1823150
28.

Ankle arthrodesis in children.

Mazur JM, Cummings RJ, McCluskey WP, Lovell WW.

Clin Orthop Relat Res. 1991 Jul;(268):65-9. Review.

PMID:
2060229
29.

Dose-response study of ultraviolet radiation for induction of photoallergy to tetrachlorosalicylanilide in guinea pigs.

Lovell WW, Sanders DJ.

Photodermatol Photoimmunol Photomed. 1990 Oct;7(5):192-7.

PMID:
2091742
30.

Screening test for phototoxins using solutions of simple biochemicals.

Lovell WW, Sanders DJ.

Toxicol In Vitro. 1990;4(4-5):318-20.

PMID:
20702186
31.

The cavovarus foot deformity. Etiology and management.

McCluskey WP, Lovell WW, Cummings RJ.

Clin Orthop Relat Res. 1989 Oct;(247):27-37. Review.

PMID:
2676298
32.

Photoallergic potential in the guinea-pig of the nitromusk perfume ingredients musk ambrette, musk moskene, musk xylene, musk ketone, and musk tibetene.

Lovell WW, Sanders DJ.

Int J Cosmet Sci. 1988 Dec;10(6):271-9. doi: 10.1111/j.1467-2494.1988.tb00027.x.

PMID:
19456941
33.

Operative treatment of congenital idiopathic club foot.

Cummings RJ, Lovell WW.

J Bone Joint Surg Am. 1988 Aug;70(7):1108-12. Review. No abstract available.

PMID:
3042792
34.

[Diseases of the Old World and indigenous mortality: smallpox and typhus in the Cuchumatanes range of Guatemala].

Lovell WG.

Mesoamerica (Antigua Guatem). 1988;9(16):239-85. Spanish. No abstract available.

PMID:
11635386
35.

Induction of photoallergy in guinea-pigs by injection of photoallergen-protein conjugates.

Barratt MD, Goodwin BF, Lovell WW.

Int Arch Allergy Appl Immunol. 1987;84(4):385-9.

PMID:
3679565
36.

The Altdorf hip clamp.

Alonso JE, Lovell WW, Lovejoy JF.

J Pediatr Orthop. 1986 Jul-Aug;6(4):399-402.

PMID:
3734061
37.

Congenital absence of the lung.

Meehan PL, Lovell WW, Ahn JI.

J Pediatr Orthop. 1985 Nov-Dec;5(6):708-10.

PMID:
4066947
38.

Surgical fusion in childhood spondylolisthesis.

Stanton RP, Meehan P, Lovell WW.

J Pediatr Orthop. 1985 Jul-Aug;5(4):411-5.

PMID:
4019752
39.

Modified Hoke-Miller flatfoot procedure.

Duncan JW, Lovell WW.

Clin Orthop Relat Res. 1983 Dec;(181):24-7.

PMID:
6641059
40.

Scoliosis secondary to an osteoid-osteoma of the rib. A case report.

Kehl DK, Alonso JE, Lovell WW.

J Bone Joint Surg Am. 1983 Jun;65(5):701-3. No abstract available.

PMID:
6853580
41.

Congenital pseudarthrosis of the tibia. A long-term follow-up study.

Murray HH, Lovell WW.

Clin Orthop Relat Res. 1982 Jun;(166):14-20.

PMID:
6805994
42.

Historia demográfica de la sierra de los cuchumatanes, Guatemala: 1520-1821.

Lovell WG.

Mesoamerica (Antigua Guatem). 1982;3(4):279-301. Spanish. No abstract available.

PMID:
11635383
43.

Congenital elevation of the scapula. Surgical correction by the Woodward procedure.

Carson WG, Lovell WW, Whitesides TE Jr.

J Bone Joint Surg Am. 1981 Oct;63(8):1199-207.

PMID:
7026567
44.

The American Orthopaedic Association and its vested interests.

Lovell WW.

J Bone Joint Surg Am. 1980 Dec;62(8):1385-7. No abstract available.

PMID:
7440622
45.

Thompson Arthrodesis of the hip in children.

Price CT, Lovell WW.

J Bone Joint Surg Am. 1980 Oct;62(7):1118-23.

PMID:
7430197
46.

Preliminary experience with the Scottish Rite Hospital abduction orthosis for Legg-Perthes disease.

Purvis JM, Dimon JH 3rd, Meehan PL, Lovell WW.

Clin Orthop Relat Res. 1980 Jul-Aug;(150):49-53.

PMID:
7428242
47.

Treatment of congenital clubfoot.

Lovell WW, Farley D.

ONA J. 1979 Nov;6(11):453-6. No abstract available.

PMID:
261546
48.

Hoke triple arthrodesis.

Duncan JW, Lovell WW.

J Bone Joint Surg Am. 1978 Sep;60(6):795-8.

PMID:
701313
49.

Progressive infantile idiopathic scoliosis.

Hopper WC Jr, Lovell WW.

Clin Orthop Relat Res. 1977 Jul-Aug;(126):26-32.

PMID:
598128
50.

Sickle cell anemia: erythrokinetics, blood volumes, and a study of possible determinants of severity.

Steinberg MH, Dreiling BJ, Lovell WJ.

Am J Hematol. 1977;2(1):17-23.

PMID:
868865

Supplemental Content

Loading ...
Support Center